In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Endo divests Grupo Farmaceutico Somar to PE firm Advent International

Executive Summary

Endo International PLC divested Grupo Farmaceutico Somar to private equity investor Advent International for $124mm in cash.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Full Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register